Gemzar (Gemcitabine) 1000mg IV LYLLY France
Interchangeable drugs with the same active ingredient:
squealing
Hematix
Gemzar
Hemita
Gemtero
Gemzibin
Gemcitabine
Gemcitabine "Ebewe"
Gemcitabine "Ebewe"
Gemcitabine Amaxa
Gemcitabine Medac
Gemcitabine-Teva
Gemcitabine-Vista
Gemcitabine-Pharmex
Gemcitera
Hertzizar
Dertsin
Oncohem
Oncoril
Oncoril-Health
strigem
Tolgecit
cytoheme
Indications:
Primary therapy for local progressive or metastatic non-small cell lung cancer (as monotherapy or in combination with cisplatin).
Locally advanced or metastatic pancreatic cancer.
Inoperable or metastatic bladder cancer.
Unresectable, locally recurrent or metastatic breast cancer that has recurred after adjuvant/neoadjuvant chemotherapy (in combination with paclitaxel). In the absence of clinical contraindications, prior chemotherapy with an anthracycline should be performed.
Recurrent epithelial ovarian cancer, when relapses were observed more than 6 months after platinum therapy (in combination with carboplatin).
-
Commercial name:Gemzar
-
Сhemical name:Gemcitabine
-
Dosage:1000 mg
-
Release form:Ampoule